Skip to main content
Top
Published in: Clinical Rheumatology 12/2011

01-12-2011 | Brief Report

Foot health needs in people with systemic sclerosis: an audit of foot health care provision

Authors: Begonya Alcacer-Pitarch, Heidi J. Siddle, Maya H. Buch, Paul Emery, Farina Hashmi, Anthony C. Redmond

Published in: Clinical Rheumatology | Issue 12/2011

Login to get access

Abstract

The vascular and cutaneous alterations evident in systemic sclerosis/scleroderma (SSc) place the foot at risk of ulceration. The UK Podiatry Rheumatic Care Association (PRCA)/Arthritis and Musculoskeletal Alliance standards of care recommend that all people with SSc should receive at least basic information about their foot health, and that those with foot problems should have access to self-management advice and care where needed. The aim of this study was to evaluate foot health services offered in Leeds (UK) for people with SSc, against nationally agreed standards of care. Ninety-one consecutive patients with SSc were selected from either the connective tissue disease outpatient clinic (n = 70) or the specialist rheumatology foot health clinic (n = 21) at Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust. All the patients completed a disease-specific audit tool developed by the UK PRCA that evaluates provision of foot health care for patients with SSc. Sixty-one patients (67%) reported having had foot problems at some point in time and 54 (59%) had current foot problems. Of these 54 patients, 17 (32%) had not received any foot care. Only 36 (39%) of the 91 patients had received any foot health information. This audit demonstrates that patients with SSc have a relatively high prevalence of self-reported foot problems. Foot health care and information are inadequate for people with SSc and foot problems, and preventative information is almost non-existent. Improved foot health information will better empower patients to self-manage low risk problems, and help identify high risk problems which require specialist care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Della Rossa A, Valentini G (2001) European multicentre study to define disease activity criteria for systemic sclerosis. Clinical and epidemiological features of 290 patients for 19 centres. Ann Rheum Dis 60:585–591PubMedCrossRef Della Rossa A, Valentini G (2001) European multicentre study to define disease activity criteria for systemic sclerosis. Clinical and epidemiological features of 290 patients for 19 centres. Ann Rheum Dis 60:585–591PubMedCrossRef
2.
go back to reference Balbir-Gurman A, Denton CP, Nichols B, Knight CJ, Nahir AM, Martin G, Black CM (2002) Non-invasive measurement of biomechanical skin properties in systemic sclerosis. Ann Rheum Dis 61:237–241PubMedCrossRef Balbir-Gurman A, Denton CP, Nichols B, Knight CJ, Nahir AM, Martin G, Black CM (2002) Non-invasive measurement of biomechanical skin properties in systemic sclerosis. Ann Rheum Dis 61:237–241PubMedCrossRef
3.
go back to reference Abraham D, Varga J (2005) Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol 26(11):587–595PubMedCrossRef Abraham D, Varga J (2005) Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol 26(11):587–595PubMedCrossRef
4.
go back to reference Allcock RJ, Forrest I, Corris PA, Crook PR, Griffiths ID (2004) A study of the prevalence of systemic sclerosis in northeast England. Rheumatology 43:596–602PubMedCrossRef Allcock RJ, Forrest I, Corris PA, Crook PR, Griffiths ID (2004) A study of the prevalence of systemic sclerosis in northeast England. Rheumatology 43:596–602PubMedCrossRef
6.
go back to reference Robert-Thompson PJ, Walker JG, Lu TY, Esterman T, Hakendorf AP, Smith MD, Ahern MJ (2006) Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation. Intern Med J 36:489–497CrossRef Robert-Thompson PJ, Walker JG, Lu TY, Esterman T, Hakendorf AP, Smith MD, Ahern MJ (2006) Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation. Intern Med J 36:489–497CrossRef
7.
go back to reference Wilson L (1997) Cost-of-illness of scleroderma: the case for rare diseases. Semin Arthritis Rheum 27(2):73–84PubMedCrossRef Wilson L (1997) Cost-of-illness of scleroderma: the case for rare diseases. Semin Arthritis Rheum 27(2):73–84PubMedCrossRef
8.
go back to reference Sari-Kouzel H, Hutchinson CE, Middleton A, Webb F, Moore T, Griffin K, Herrick AL (2001) Foot problems in patients with systemic sclerosis. Rheumatology (Oxford) 40:410–413CrossRef Sari-Kouzel H, Hutchinson CE, Middleton A, Webb F, Moore T, Griffin K, Herrick AL (2001) Foot problems in patients with systemic sclerosis. Rheumatology (Oxford) 40:410–413CrossRef
9.
go back to reference La Montagna G, Baruffo A, Tirri R, Buono G, Valentini G (2002) Foot involvement in systemic sclerosis: a longitudinal study of 100 patients. Semin Arthritis Rheum 31:248–255PubMedCrossRef La Montagna G, Baruffo A, Tirri R, Buono G, Valentini G (2002) Foot involvement in systemic sclerosis: a longitudinal study of 100 patients. Semin Arthritis Rheum 31:248–255PubMedCrossRef
10.
go back to reference Hafner J, Schneider E, Burg G, Cassina P (2000) Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis. J Vasc Surg 32:322–329PubMedCrossRef Hafner J, Schneider E, Burg G, Cassina P (2000) Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis. J Vasc Surg 32:322–329PubMedCrossRef
11.
go back to reference Matucci-Cerinic M, Seinold JR (2008) Digital ulcers and outcomes assessment in scleroderma. Rheumatology 47:v46–v47PubMedCrossRef Matucci-Cerinic M, Seinold JR (2008) Digital ulcers and outcomes assessment in scleroderma. Rheumatology 47:v46–v47PubMedCrossRef
12.
go back to reference Guiducci S, Giacomelli R, Cerinic MM (2007) Vascular complications of scleroderma. Autoimmun Rev 6:520–523PubMedCrossRef Guiducci S, Giacomelli R, Cerinic MM (2007) Vascular complications of scleroderma. Autoimmun Rev 6:520–523PubMedCrossRef
13.
go back to reference Amanzi L, Braschi F, Fiori G, Galluccio F, Miniati I, Guiducci S, Conforti ML, Kaloudi O, Nacci F, Sacu O, Candelieri A, Pignone A, Rasero L, Conforti D, Matucci-Cerinic M (2010) Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology (Oxford) 49:1374–1382CrossRef Amanzi L, Braschi F, Fiori G, Galluccio F, Miniati I, Guiducci S, Conforti ML, Kaloudi O, Nacci F, Sacu O, Candelieri A, Pignone A, Rasero L, Conforti D, Matucci-Cerinic M (2010) Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology (Oxford) 49:1374–1382CrossRef
14.
go back to reference Ho M, Veale D, Eastmond C, Nuki G, Belch J (2000) Macrovascular disease and systemic sclerosis. Ann Rheum Dis 59:39–43PubMedCrossRef Ho M, Veale D, Eastmond C, Nuki G, Belch J (2000) Macrovascular disease and systemic sclerosis. Ann Rheum Dis 59:39–43PubMedCrossRef
17.
go back to reference Menz HB, Gill TK, Taylor AW, Hill CL (2008) Predictors of podiatry utilisation in Australia: the North West Adelaide Health Study. J Foot Ankle Res 1(1):8PubMedCrossRef Menz HB, Gill TK, Taylor AW, Hill CL (2008) Predictors of podiatry utilisation in Australia: the North West Adelaide Health Study. J Foot Ankle Res 1(1):8PubMedCrossRef
18.
go back to reference Garrow A, Silman A, Macfarlane G (2004) The Cheshire foot pain and disability survey: a population survey assessing prevalence and associations. Pain 110:378–384PubMedCrossRef Garrow A, Silman A, Macfarlane G (2004) The Cheshire foot pain and disability survey: a population survey assessing prevalence and associations. Pain 110:378–384PubMedCrossRef
Metadata
Title
Foot health needs in people with systemic sclerosis: an audit of foot health care provision
Authors
Begonya Alcacer-Pitarch
Heidi J. Siddle
Maya H. Buch
Paul Emery
Farina Hashmi
Anthony C. Redmond
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 12/2011
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1784-4

Other articles of this Issue 12/2011

Clinical Rheumatology 12/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine